Search

everythinglearnresearchcommunity

for

Search:↓

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Mutant CDP/Cux protein causes hair defects and reduced male fertility in mice.

Mutants of CYP154C2 enzyme significantly improved steroid conversion efficiency.

Some people have a genetic variation that makes them less effective at breaking down drugs.

Lack of Cisd2 disrupts calcium balance in cells, leading to poorly functioning neutrophils.

Variation in the TCHH gene affects wool curliness in sheep.

Certain genetic variants impair enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Modified β-catenin causes different effects in hair and skin cells, leading to cysts or tumors.

Genetic differences affect COVID-19 severity and treatment effectiveness.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Truncating mutations in the C2orf37 gene cause Woodhouse–Sakati syndrome.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

Hair root analysis can effectively detect somatic mosaicism in double cortex syndrome.

The -866G/A polymorphism in the UCP2 gene is not linked to polycystic ovary syndrome.

Genetic screening can help diagnose and manage infertility in Slovenian couples.

Micrografting is the most effective surgical method for permanent hair restoration.

New mutations in the EBP gene cause CDPX2, affecting bones, skin, eyes, and hair, with females generally less affected than males.

Female cuckoo color differences are linked to their unique genes and help avoid male harassment.

The CTLA-4 gene polymorphism does not affect polycystic ovarian syndrome.

A specific gene change in APCDD1 increases the risk of hair loss.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Modified β-catenin can cause different effects in mouse skin cells, leading to cysts or tumors depending on the cell type.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Different crystal forms of drugs can change their effectiveness.

A specific gene change plus an additional mutation in the same gene cause hereditary trichilemmal cysts.

The protein CCN2 controls hair growth by affecting hair follicle formation and stem cell activity in mice.